|
Monday, March 24 — 1:00 PM — Cotillion North
Click on the numbers in parentheses to display abstracts.
Section D - BREAST PATHOLOGY
Chaired by: Craig Allred and Roy Jensen
| 1:00 |
Gene Expression Differences between Paired Primary and Metastatic Breast Carcinomas
(116)
D Giri, M Donaton, A Olshen, K Panageas, P Lal, S Levcovici, E Brogi, C Hudis, K Van Zee, L Tan, W Gerald
Memorial Sloan Kettering Cancer Center, New York; Rhode Island Hospital, Providence, RI
|
| 1:15 |
Expression of NTRK3 (TRKC) in Human Breast Cancers: A Tissue Microarray Study
(164)
N Makretsov, PHB Sorensen, E Yorida, A Coldman, B Gilks, D Huntsman
University of British Columbia and Vancouver General Hospital; Children's and Women Health Centre of British Columbia, and British Columbia Cancer Agency, Vancouver, BC, Canada
|
| 1:30 |
Characterization of WISP3, a Novel Tumor Suppressor Gene for Inflammatory Breast Cancer, in Normal Breast and Breast Disease
(152)
CG Kleer, Y Zhang, AM Chinnaiyan, K Griffith, SD Merajver
University of Michigan, Ann Arbor, MI
|
| 1:45 |
CRxA-01 and Mammaglobin Expression in Breast Cancer: Potential Role in Differentiating Breast Cancer from Other CK7+/CK20- Tumors
(205)
D Stachurski, G Fanger, B Xu, K Edmiston, MD Wertheimer, KL Rock, A Khan
University of Massachusetts Medical School, Worcester, MA; Corixa Corporation, Seattle, WA
|
| 2:00 |
Metaplastic Carcinomas, Matrix-Producing Type (Matrix-Producing Carcinomas) of the Breast Exhibit a Myoepithelial Histogenesis
(91)
SH Barsky, G Shanmugasundaram, D Wu
UCLA School of Medicine, Los Angeles, CA
|
| 2:15 |
Chromosome Imbalances Detected by Comparative Genomic Hybridization (CGH) Are Markers of Malignant Phyllodes Tumors of the Breast
(156)
M Lae, I Huon, P Freneaux, A Vincent-Salomon, X Sastre-Garau, J Couturier
Institut Curie, Paris, France
|
| 2:30 |
Comparison of Novel Myoepithelial Cell Immunohistochemical Markers with More Established Immunomarkers in the Human Breast
(192)
JS Saenger, BL Strauss, GL Bratthauer, R Barner, RS Vang
Armed Forces Institute of Pathology, Washington, DC
|
| 2:45 |
Expression of Potential Therapeutic Targets C0X2 and c-kit in Breast Cancer: Assessment and Correlations Using Tissue Microarrays
(126)
AM Gown, H Yaziji, HC Hwang, TS Barry, TO Nielsen, FD Hsu, CE Bacchi
PhenoPath Laboratories and IRIS, Seattle, WA; University of British Columbia, Vancouver, BC, Canada; UNESP, Botucatu, SP, Brazil
|
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
|
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Dr. Irving L. Weissman
Stem Cell Biology: Past, Present and Future
Marriott Ballroom
|
|
|
